MedPage Today

Genomic and Immunophenotypic Landscape of Acquired Resistance to PD-(L)1 Blockade in Non–Small-Cell Lung Cancer

Biagio Ricciuti, MD, PhD, Giuseppe Lamberti, MD, PhD, Sreekar R. Puchala, PhD, Navin R. Mahadevan, MD, PhD, Jia-Ren Lin, PhD, Joao V. Alessi, MD, Alexander Chowdhury ...
ascopubs.org

Immunophenotypic correlates and response to first-line pembrolizumab among elderly patients with PD-L1-high (≥ 50%) non–small cell lung cancer.

Impact of performance status on survival outcomes and health care utilization in patients with advanced non–small cell lung cancer treated with immune checkpoint inhibitors. This is an ASCO Meeting ...
Nature

Immunophenotypic changes in the tumor and tumor microenvironment during progression to multiple myeloma

The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...
ascopubs.org

Genomic and Immunophenotypic Landscape of Acquired Resistance to PD-(L)1 Blockade in Non–Small-Cell Lung Cancer

Poor Concordance Between Cancer Antigen-125 and RECIST Assessment for Progression in Patients With Platinum-Sensitive Relapsed Ovarian Cancer on Maintenance Therapy With a Poly(ADP-ribose) Polymerase ...